Skip to main content
Pharmaceutical product and formulation background
Pharmaceutical Division

Vamorolone

Vamorolone is a dissociative steroidal anti-inflammatory drug being developed for the treatment of Duchenne muscular dystrophy.

Under developmentDuchenne Muscular Dystrophy (DMD)CAS 13209-41-1
✓Quality Assured
✓Dissociative steroidal anti-inflammatory
✓Under development

Detailed technical, regulatory, and supply information is available for commercial evaluation.

Technical Overview

Vamorolone – CAS 13209-41-1

Under development

CAS Number

13209-41-1

Category

Duchenne Muscular Dystrophy (DMD)

Therapeutic Class

Dissociative steroidal anti-inflammatory

Description

Vamorolone is a dissociative steroidal anti-inflammatory drug being developed for the treatment of Duchenne muscular dystrophy.

Applications

  • Duchenne muscular dystrophy

Handling & Supply Details

Packaging

Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.

Product Inquiry

Disclaimer

Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.

This website uses cookies to optimize your navigation and adapt to your preferences. You can continue browsing without accepting. If you select "Accept", you accept the use of ALL cookies. You can also select cookies in "Cookie settings" and consult our Cookies Policy and Privacy Policy here.